These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 2919892

  • 1. [Combination chemo-endocrine therapy of metastatic and stage IV breast cancer with cyclophosphamide, adriamycin, prednisolone and tamoxifen (CAPT)--with special reference to management of brain and liver metastasis].
    Nakamura Y, Kawaguchi M, Hata A, Watanabe H, Ueki Y, Oribe T, Koba F, Takamuku K.
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):243-50. PubMed ID: 2919892
    [Abstract] [Full Text] [Related]

  • 2. [Adriamycin, cyclophosphamide, ftorafur and tamoxifen (ACFT) in patients with advanced breast cancer].
    Imajo K, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Ozeki H, Nagamine D, Shinagawa K, Fukutani H.
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):121-6. PubMed ID: 3122665
    [Abstract] [Full Text] [Related]

  • 3. [A study of complete responders in cases of metastatic breast cancer treated with combination chemotherapy].
    Shinagawa K, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Fukutani H, Tabata M, Hirano A, Mizunuma N.
    Gan No Rinsho; 1989 Apr; 35(5):581-6. PubMed ID: 2541272
    [Abstract] [Full Text] [Related]

  • 4. [A study on the efficacy of combination chemoendocrine therapy consisting of cyclophosphamide, adriamycin, UFT, and tamoxifen for advanced or recurrent breast cancer].
    Yamaguchi S, Fukuda M, Ota T, Nakayama Y, Ogata H, Shimizu K, Nishikawa T, Adachi Y, Fukuma E.
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1145-52. PubMed ID: 10431580
    [Abstract] [Full Text] [Related]

  • 5. [Combined chemoendocrine therapy using adriamycin, cyclophosphamide and high dose toremifene in patients with recurrent breast cancer].
    Wada N, Kobayashi H, Oka S, Ando J, Tamura H.
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1935-42. PubMed ID: 12465393
    [Abstract] [Full Text] [Related]

  • 6. [The clinical efficacy of CAC regimen in the treatment of advanced breast cancer].
    Zhang P, Zhou J, Feng F.
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):365-7. PubMed ID: 8697977
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL, Sheen TS, Ko JY, Hsu MM, Wang CC, Ting LL.
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [Abstract] [Full Text] [Related]

  • 9. [Phase II study of combination chemotherapy with epirubicin, cyclophosphamide and ftorafur in metastatic breast cancer].
    Shinagawa K, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Fukutani H, Tabata M, Hirano A, Mizunuma N.
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3277-81. PubMed ID: 3143311
    [Abstract] [Full Text] [Related]

  • 10. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H, Sakai K, Oka T, Ozawa K, Saito Y, Senoo T, Taguchi T, Terasawa T, Nakao K, Mori T, Koyama H, Oshima A.
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [Abstract] [Full Text] [Related]

  • 11. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, Smith T, Buzdar A, Hortobagyi GN.
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [Abstract] [Full Text] [Related]

  • 12. Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma.
    Cheng AL, Yeh KH, Fine RL, Chuang SE, Yang CH, Wang LH, Chen DS.
    Hepatogastroenterology; 1998 Jul; 45(24):1955-60. PubMed ID: 9951847
    [Abstract] [Full Text] [Related]

  • 13. [A case report of advanced breast cancer effectively treated by chemo-endocrine therapy with diethylstilbestrol diphosphate and cyclophosphamide].
    Hareyama M, Saito A, Oouchi A, Morita K.
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2453-6. PubMed ID: 2751322
    [Abstract] [Full Text] [Related]

  • 14. [ACFT therapy using adriamycin, cyclophosphamide, tegafur and tamoxifen against progressive breast cancer].
    Watanabe Y, Tamura M, Meguro F.
    Gan To Kagaku Ryoho; 1988 May; 15(5):1711-4. PubMed ID: 3130805
    [Abstract] [Full Text] [Related]

  • 15. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
    Arcangeli G, Righini R, Nervi C, Guerra A, Tirindelli D, Hopkins H, Looney W.
    Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
    [Abstract] [Full Text] [Related]

  • 16. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.
    Swain SM, Sorace RA, Bagley CS, Danforth DN, Bader J, Wesley MN, Steinberg SM, Lippman ME.
    Cancer Res; 1987 Jul 15; 47(14):3889-94. PubMed ID: 3036348
    [Abstract] [Full Text] [Related]

  • 17. Combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in advanced breast carcinoma.
    Dalley DN, Levi JA, Aroney RS.
    Med J Aust; 1980 Mar 08; 1(5):216-8. PubMed ID: 6990214
    [Abstract] [Full Text] [Related]

  • 18. Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery.
    Lippman ME, Sorace RA, Bagley CS, Danforth DW, Lichter A, Wesley MN.
    NCI Monogr; 1986 Mar 08; (1):153-9. PubMed ID: 3022156
    [Abstract] [Full Text] [Related]

  • 19. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
    Ardavanis A, Extra JM, Espié M, Cuvier C, Marty M.
    In Vivo; 1998 Mar 08; 12(5):559-62. PubMed ID: 9827368
    [Abstract] [Full Text] [Related]

  • 20. [Efficacy of combination therapy consisting of cyclophosphamide, adriamycin, UFT and oophorectomy/tamoxifen for advanced or recurrent breast cancer].
    Kiman K, Suzuki S, Satomi T, Sakonji M, Nihei M, Tanaka T, Kimijima I, Abe R.
    Gan To Kagaku Ryoho; 1994 Oct 08; 21(14):2445-52. PubMed ID: 7944490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.